» Articles » PMID: 35937309

A Case-Control Study of the MTHFR C665T Gene Polymorphism on Macrocytic Anemia Among HIV-Infected Patients Receiving Zidovudine

Overview
Publisher Dove Medical Press
Specialty Health Services
Date 2022 Aug 8
PMID 35937309
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Macrocytic anemia is the most common anemia in HIV-infected patients receiving zidovudine, and is closely related to folate and vitamin B12 deficiencies. Homocysteine >10 μmol/L and increased MMA (methylmalonic acid) levels >24.8 ng/mL indicate high/low folate and vitamin B12 deficiencies. Furthermore, MTHFR (Methylene-tetrahydrofolate-reductase) plays an essential role in the transmethylation of homocysteine to methionine and is related to DNA synthesis. The MTHFR C665T gene polymorphism decreases the activity of MTHFR, which culminates in homocysteinemia. Therefore, this case-control aims to assess the role of the MTHFR C665T gene polymorphism on the risk of macrocytic anemia among HIV-infected individuals receiving zidovudine.

Methods: This study was conducted using an unmatched case-control design and the participants were HIV-infected adults aged 20 to 59 years old, receiving zidovudine for four weeks and above. A sample of 232 patients was divided into case group with macrocytic anemia and the control having no anemia. Multivariate logistic regression analysis was then implemented to determine the risk factors.

Results: The results showed that there was a significant difference in the number of female and male patients namely 51.3% and 48.7%, respectively, with p< 0.001. Moreover, the mean age of the cases and control group was 41.9 ± 9.4 and 36.2 ± 8.3. Regarding education, there were significant differences between subjects with low and high education 47.8% vs 52.2% with p<0.001. The majority of patients or 90.95% had taken AZT for more than 6 months. The logistic regression analysis test results showed that sex, age, education level, duration of AZT use, and homocysteine levels were predictors of macrocytic anemia with p<0.05, while MTHFR C665T gene polymorphism and MMA levels were not risk factors.

Conclusion: MTHFR C665T gene polymorphism does not contribute to the incidence of macrocytic anemia among HIV-infected individuals receiving zidovudine.

Citing Articles

Incidence and Risk Factors of Zidovudine-Induced Anemia in Patients With HIV Infection Receiving Zidovudine-Containing Antiretroviral Therapy.

Boonyagars L, Thinpangnga P, Munsakul W J Int Assoc Provid AIDS Care. 2025; 24:23259582251321577.

PMID: 39967242 PMC: 11863231. DOI: 10.1177/23259582251321577.


A rare case report of severe aplastic anaemia caused by long-term use of zidovudine.

Zhou J, Wang Q, Yu Y, Chen L, Shi J, Huang C BMC Infect Dis. 2024; 24(1):1421.

PMID: 39695951 PMC: 11653540. DOI: 10.1186/s12879-024-09875-z.

References
1.
Mahajan S, Aundhakar S . A study of the prevalence of serum vitamin B12 and folic Acid deficiency in Western maharashtra. J Family Med Prim Care. 2015; 4(1):64-8. PMC: 4367008. DOI: 10.4103/2249-4863.152255. View

2.
Kiragga A, Castelnuovo B, Nakanjako D, Manabe Y . Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings. J Int AIDS Soc. 2010; 13:42. PMC: 2991285. DOI: 10.1186/1758-2652-13-42. View

3.
Mihiretie H, Taye B, Tsegaye A . Magnitude of Anemia and Associated Factors among Pediatric HIV/AIDS Patients Attending Zewditu Memorial Hospital ART Clinic, Addis Ababa, Ethiopia. Anemia. 2015; 2015:479329. PMC: 4387982. DOI: 10.1155/2015/479329. View

4.
Guo S, Pang H, Guo H, Zhang M, He J, Yan Y . Ethnic differences in the prevalence of high homocysteine levels among low-income rural Kazakh and Uyghur adults in far western China and its implications for preventive public health. Int J Environ Res Public Health. 2015; 12(5):5373-85. PMC: 4454973. DOI: 10.3390/ijerph120505373. View

5.
Al-Batayneh K, Al Zoubi M, Shehab M, Al-Trad B, Bodoor K, Al Khateeb W . Association between MTHFR 677C>T Polymorphism and Vitamin B12 Deficiency: A Case-control Study. J Med Biochem. 2018; 37(2):141-147. PMC: 6294092. DOI: 10.1515/jomb-2017-0051. View